WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Two Techniques of IV Lidocaine on Propofol Injection Pain

Phase 4

Completed

Conditions: Injections, Intravenous

Interventions: Drug: Lidocaine injection flushed
Drug: Lidocaine injection tourniquet

First Posted Date: 2017-02-20

Last Posted Date: 2018-09-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 50

Registration Number: NCT03057704

Locations: 🇺🇸
North Carolina Baptist Hospital, Winston-Salem, North Carolina, United States

Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma

Phase 2

Completed

Conditions: Soft Tissue Sarcoma, Adult
Soft Tissue Sarcoma, Child

Interventions: Drug: Pembrolizumab
Drug: Doxorubicin

First Posted Date: 2017-02-16

Last Posted Date: 2023-11-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 30

Registration Number: NCT03056001

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Sedation Methods During Cataract Surgery

Phase 4

Completed

Conditions: Phacoemulsification
Cataract

Interventions: Drug: Midazolam + Normal saline

First Posted Date: 2017-02-15

Last Posted Date: 2018-09-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 105

Registration Number: NCT03054103

MED in UVB Devices in the Presence and Absence of UV Filter

Not Applicable

Withdrawn

Conditions: Healthy Participants and/or Patients

Interventions: Device: Psoriashield in the presence of a non-UV absorbing block.
Device: Psoriashield in the presence of a UV absorbing block.
Device: Psoriashield
Device: Xtrac laser in the presence of a non-UV absorbing block.
Device: Xtrac in the presence of a UV absorbing block.
Device: Xtrac laser

First Posted Date: 2017-02-10

Last Posted Date: 2019-08-29

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03049319

Locations: 🇺🇸
Elias Oussedik, Winston-Salem, North Carolina, United States

Evaluating Treatment Resistant Dermatitis TaroIIR

Phase 4

Completed

Conditions: Psoriasis
Atopic Dermatitis

Interventions: Behavioral: Phone calls
Drug: Desoximetasone 0.25% spray

First Posted Date: 2017-02-10

Last Posted Date: 2020-05-20

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 24

Registration Number: NCT03050294

Locations: 🇺🇸
Wake Forest University Health Sciences Department of Dermatology, Winston-Salem, North Carolina, United States

Internet Surveys and Their Impact on Adherence for Rosacea

Phase 4

Completed

Conditions: Rosacea

Interventions: Drug: brimonidine topical gel 0.33% & SOC
Drug: brimonidine topical gel 0.33% & survey

First Posted Date: 2017-02-09

Last Posted Date: 2018-10-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT03048058

Locations: 🇺🇸
Dept of Dermatology, WFUHS, Winston-Salem, North Carolina, United States

Evaluating Dysphagia in Neonates With CHD

Terminated

Conditions: Dysphagia of Newborn

First Posted Date: 2017-02-07

Last Posted Date: 2024-10-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03045757

Locations: 🇺🇸
Advocate Children's Hospital, Oak Lawn, Illinois, United States

Pre-Shave Gel and Brush in Pseudofolliculitis Barbae

Not Applicable

Completed

Conditions: Pseudofolliculitis Barbae

Interventions: Other: shave gel
Other: Brush

First Posted Date: 2017-02-06

Last Posted Date: 2018-12-19

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 29

Registration Number: NCT03043534

Locations: 🇺🇸
Wake Forest University Health Sciences Dept of Dermatology, Winston-Salem, North Carolina, United States

Cryosurgery and Cream Combination for Actinic Keratosis

Phase 3

Completed

Conditions: Actinic Keratosis

Interventions: Drug: Placebo Cetaphil cream
Drug: Carac Cream

First Posted Date: 2017-01-31

Last Posted Date: 2018-08-29

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03037541

Locations: 🇺🇸
Wake Forest University Health Sciences Department of Dermatology, Winston-Salem, North Carolina, United States

COcoa Supplement and Multivitamin Outcomes Study for the Mind

Completed

Conditions: Dementia
Aging
Cognitive Impairment

First Posted Date: 2017-01-27

Last Posted Date: 2023-08-22

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 2262

Registration Number: NCT03035201

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy